Sort
64,565 grants matching “drug discovery”
Genetic Analysis of Toxinogenesis in Vibrio Cholerae
$645,629John J Mekalanos · Harvard Medical School · R01 · FY2010 · AI
Positive Allosteric Modulators as PET Imaging Ligans for mGluR4
$645,610Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2017 · NS
Broad-spectrum therapeutics against SARS-CoV-2 3CL protease
$645,603Raymond F. Schinazi · Emory University · R01 · FY2024 · AI
Development and Characterization of Small Molecule Activators of Peptidase Neurolysin for Stroke Therapy
$645,589Vardan T. Karamyan · Oakland University · R01 · FY2025 · NS
Structural Basis of Signal Instigation Through Family C GPCRs
$645,521Georgios Skiniotis · Stanford University · R01 · FY2021 · NS
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
$645,460William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Public HIV Drug Resistance Database
$645,430Robert W Shafer · Stanford University · R01 · FY2006 · AI
Discovery of Novel Inhibitors Targeting trans-Golgi Network Acidification in Pancreatic Cancer
$645,331Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · CA
In vivo HTS assay for novel modulators of Apolipoprotein B
$645,300Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2020 · DK
FOUR-HELIX BUNDLE ANALOG OF A G-PROTEIN COUPLED RECEPTOR
$645,264Three-Dimensional Pharmaceuticals, Inc. · R44 · FY2000 · GM
Small Molecule Discovery for Particulate Guanylyl Cyclase Receptor B Enhancers
$645,210Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2017 · AG
ADMINISTRATION (Admin Core)
$645,148Timothy L Ratliff · Purdue University · P30 · FY2018 · CA
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
$645,142Elliot J Androphy · Indiana University Indianapolis · R01 · FY2022 · CA
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
$644,932David Eric Gerber · Ut Southwestern Medical Center · U10 · FY2018 · CA
NOVEL GROUP A STREPTOCOCCUS HUMAN VACCINE CANDIDATES
$644,804Baylor College Of Medicine · U01 · FY2004 · AI
Development of antibacterial agents and materials
$644,785Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Defining the Mechanistic Basis of Bacterial Androgen Production in Dampening Anti-Tumor Immunity and Promoting Resistance to Androgen Receptor Axis-Targeted Therapies for Metastatic Prostate Cancer
$644,763Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2025 · CA
Integrating Radiomics into S0819 and Lung-MAP, Biomarker Driven Clinical Trials for Lung Cancer
$644,727Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2018 · CA
Engineering Knotted Peptide Therapeutics for Pediatric Brain Tumor Patients
$644,689James M Olson · Seattle Children'S Hospital · R01 · FY2022 · CA
Structure-based strategy for developing inhibitors of the kidney chloride channel CLC-Ka
$644,671Merritt C Maduke · Stanford University · R01 · FY2022 · DK
Profiling the Leishmania-macrophage Host-pathogen Infectome
$644,663Najib M. El-Sayed · Univ Of Maryland, College Park · R01 · FY2012 · AI
Systemic RNA Delivery to Tumors
$644,550Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2016 · CA
Development of Allopregnanolone as a Neurogenic Regenerative Therapeutic
$644,539Roberta Diaz Brinton · University Of Southern California · U01 · FY2008 · AG
Eastern Cooperative Oncology Group Chair's Office
$644,464Robert L Comis · Drexel University · U10 · FY2007 · CA
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
$644,430Xiling Shen · Duke University · U01 · FY2020 · CA